KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) EBIAT (2016 - 2026)

Chemed filings provide 18 years of EBIAT readings, the most recent being $66.3 million for Q1 2026.

  • For the quarter ending Q1 2026, EBIAT fell 7.6% year-over-year to $66.3 million, compared with a TTM value of $259.8 million through Mar 2026, down 15.86%, and an annual FY2025 reading of $265.2 million, down 12.17% over the prior year.
  • EBIAT hit $66.3 million in Q1 2026 for Chemed, down from $76.8 million in the prior quarter.
  • The five-year high for EBIAT was $90.3 million in Q4 2024, with the low at $52.5 million in Q2 2025.
  • Median EBIAT over the past 5 years was $66.3 million (2026), compared with a mean of $68.0 million.
  • The sharpest move saw EBIAT skyrocketed 44.95% in 2023, then fell 25.95% in 2025.
  • Year by year, EBIAT stood at $62.1 million in 2022, then skyrocketed by 44.95% to $90.1 million in 2023, then grew by 0.3% to $90.3 million in 2024, then dropped by 15.02% to $76.8 million in 2025, then fell by 13.61% to $66.3 million in 2026.
  • According to Business Quant data, EBIAT over the past three periods came in at $66.3 million, $76.8 million, and $64.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.